Oncologic Surveillance for Variant Histology Bladder Cancer after Radical Cystectomy
Overactive BladderUro-Oncology
Related content
Overactive BladderUro-Oncology
Pure but Not Mixed Histologic Variants Are Associated With Poor Survival at Radical Cystectomy in Bladder Cancer Patients
Clin Genitourin Cancer.
Moschini M, Shariat SF, Lucianò R, D'Andrea D, Foerster B, Abufaraj M, Bandini M, Dell'Oglio P, Damiano R, Salonia A, Montorsi F, Briganti A, Colombo R, Gallina A
doi: 10.1016/j.clgc.2016.12.006.
Uro-Oncology
A Systematic Review and Meta-analysis of Variant Histology in Urothelial Carcinoma of the Bladder Treated with Radical Cystectomy
J Urol.
Mori K, Abufaraj M, Mostafaei H, Quhal F, Karakiewicz PI, Briganti A, Kimura S, Egawa S, Shariat SF
doi: 10.1097/JU.0000000000001305.
Overactive BladderUro-Oncology
Propensity matched comparative analysis of survival following chemoradiation or radical cystectomy for muscle-invasive bladder cancer
BJU Int
Ritch CR, Balise R, Prakash NS, Alonzo D, Almengo K, Alameddine M, Venkatramani V, Punnen S, Parekh DJ, Gonzalgo ML
doi: 10.1111/bju.14109.
Uro-Oncology
The Cancer of the Bladder Risk Assessment (COBRA) score for Estimating Cancer-Specific Survival after Radical Cystectomy: External Validation in a Large Bi-institutional Cohort
BJU Int.
Muilwijk T, Akand M, Soria F, Giordano A, Milenkovic U, Moris L, Gevaert T, Van Poppel H, Albersen M, Gontero P, Joniau S
doi: 10.1111/bju.15163.
Uro-Oncology
The prognostic impact of hexaminolevulinate-based bladder tumor resection in patients with primary non-muscle invasive bladder cancer treated with radical cystectomy
World J Urol.
Renninger M, Fahmy O, Schubert T, Schmid MA, Hassan F, Stenzl A, Gakis G
doi: 10.1007/s00345-019-02780-0.
Overactive BladderUro-Oncology
Detection and Clinical Significance of Circulating Tumor Cells in Patients Undergoing Radical Cystectomy for Urothelial Bladder Cancer
Clin Genitourin Cancer.
Pagliarulo V, Ancona P, Petitti T, Salerno A, Spadavecchia R, Di Stasi S, Cormio L, Maurizio B, Carrieri G, Ditonno P
doi: 10.1016/j.clgc.2016.11.005.
RECOMMENDED
Uro-Oncology
Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Carcinoma with Variant Histologies
★ 2
Recommended by
Prof. Dr Richard Cathomas, Faculty Member
Eur Urol.
Necchi A, Raggi D, Gallina A, Madison R, Colecchia M, Lucianò R, Montironi R, Giannatempo P, Farè E, Pederzoli F, Bandini M, Bianchi M, Colombo R, Gandaglia G, Fossati N, Marandino L, Capitanio U, Dehò F, Ali SM, Chung JH, Ross JS, Salonia A, Briganti A, Montorsi F
doi: 10.1016/j.eururo.2019.10.026.
Overactive BladderUro-Oncology
Oncological outcomes, quality of life outcomes and complications of partial cystectomy for selected cases of muscle-invasive bladder cancer
Sci Rep.
Ebbing J, Heckmann RC, Collins JW, Miller K, Erber B, Friedersdorff F, Fuller TF, Busch J, Seifert HH, Ardelt P, Wetterauer C, Hosseini A, Jentzmik F, Kempkensteffen C
doi: 10.1038/s41598-018-26089-x.
Overactive BladderUro-Oncology
Long-term Oncological Outcomes from an Early Phase Randomised Controlled Three-arm Trial of Open, Robotic, and Laparoscopic Radical Cystectomy (CORAL)
Eur Urol.
Khan MS, Omar K, Ahmed K, Gan C, Van Hemelrijck M, Nair R, Thurairaja R, Rimington P, Dasgupta P
doi: 10.1016/j.eururo.2019.10.027.